SEC Filing | Prestige Consumer Healthcare Inc.

View:

Download DOC

Download PDF

Download XLS

WebFilings | EDGAR view

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 12, 2011

PRESTIGE BRANDS HOLDINGS, INC.

(Exact name of registrant as specified in its charter)



Delaware	001-32433	20-1297589
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

90 North Broadway, Irvington, New York 10533

(Address of principal executive offices, including Zip Code)

(914) 524-6810

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

On May 12, 2011, Prestige Brands Holdings, Inc. (the ''Registrant'') announced financial results for the fiscal quarter and year ended March 31, 2011. A copy of the press release announcing the Registrant's earnings results for the fiscal quarter and year ended March 31, 2011 is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be ''filed'' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless the Registrant specifically states that the information is to be considered “filed” under the Exchange Act or incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 7.01. Regulation FD Disclosure.

The information set forth in Item 2.02 above is incorporated by reference as if fully set forth herein.

Item 9.01 Financial Statements and Exhibits.


(a)	Exhibits.

See Exhibit Index immediately following the signature page.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Dated: May 12, 2011	PRESTIGE BRANDS HOLDINGS, INC.

	By:	/s/ Ronald M. Lombardi
		Name: Ronald M. Lombardi
		Title: Chief Financial Officer

EXHIBIT INDEX



Exhibit		Description

99.1		Press Release dated May 12, 2011 announcing the Registrant's financial results for the fiscal quarter and year ended March 31, 2011 (furnished only).
99.2		Investor Relations Slideshow in use beginning May 12, 2011 (furnished only).

WebFilings | EDGAR view

Exhibit 99.1

Prestige Brands Holdings, Inc. Reports Fourth Quarter & Fiscal 2011 Results

For the Quarter, Prestige Reports Record Revenues Driven by

the Completion of Two Acquisitions and Strong OTC Organic Growth

Irvington, NY, May 12, 2011 (Business Wire)-Prestige Brands Holdings, Inc. (NYSE: PBH) today announced results for the fourth fiscal quarter and full year ended March 31, 2011.

Revenues for the fourth fiscal quarter were $96.4 million, $26.4 million or 37.8% above the prior year's quarter. Revenues of the acquired Blacksmith Brands and Dramamine® brand, completed November 1, 2010 and January 6, 2011, respectively, accounted for $23.6 million of the increase while organic revenues for the Company grew $2.8 million or 4.1% during the current quarter over the prior year comparable quarter. The Company's revenue from its organic five core OTC brands (Chloraseptic®, Clear Eyes®, Compound W®, Little Remedies® and The Doctor's® NightGuard®) increased 8.4% over the prior year comparable quarter.

Gross profit for the fourth fiscal quarter was $46.3 million, $11.3 million or 32.5% above the prior year comparable quarter of $35.0 million. Excluding charges associated with inventory valuation step-up adjustments of $3.7 million related to the Blacksmith Brands and Dramamine acquisitions, gross profit would have been $50.0 million in the current quarter. Gross margin was 48.1% in the current quarter, which was negatively impacted by 3.8 percentage points from the inventory step-up charges noted above. Excluding these charges, gross margin would have improved to 51.9% from 50.0% in the prior year comparable quarter, primarily as a result of a higher proportion of revenue generated from the Over-the-Counter Healthcare (“OTC”) segment. During the quarter the Company continued to invest strongly behind Advertising and Promotion (“A&P”) in support of its core brands within the OTC segment and the acquired brands. A&P for the quarter was $14.1 million, $7.6 million or 115.8% above the prior year

comparable quarter of $6.5 million.

Operating income for the fourth fiscal quarter was $18.6 million or 5.4% higher than the prior year comparable quarter of $17.7 million. Operating income included $4.5 million of costs associated with the acquisitions of Blacksmith and Dramamine, including the inventory step-up charges noted above. Excluding these charges, operating income would have been $23.1 million for the quarter, $5.4 million or 31.0% above the prior year comparable quarter.

Income from continuing operations for the fourth fiscal quarter was $6.4 million and was negatively impacted by the above noted costs associated with the acquisitions of $2.4 million, net of related tax effects. Income from continuing operations for the fourth fiscal quarter of the prior year was $5.8 million and was negatively impacted by $1.3 million of a loss on the extinguishment of debt, net of related tax effects. Excluding these impacts, income from continuing operations would have been $8.8 million for the current year fourth fiscal quarter compared to $7.1 million for the prior year fourth fiscal quarter, an increase of 23.8%.

Diluted earnings per share from continuing operations was $0.13 for the fourth fiscal quarter, which included costs associated with the Blacksmith and Dramamine acquisitions, compared to $0.12 in the prior year comparable quarter, which included a loss on the extinguishment of debt. Excluding the impact of these charges in each quarter, diluted earnings per share from continuing operations in the fourth fiscal quarter would have been $0.18 compared to $0.14 in the prior year comparable quarter, an increase of 28.6%.

Commentary:

“Fiscal 2011 has been an extremely productive and transformative year for Prestige Brands,” said Matthew M. Mannelly, President and CEO. “In particular, we are pleased that the Company delivered 4.1% organic revenue growth in the quarter, exclusive of acquisitions. Our strategy to build brands through increased, innovative and effective A&P support is delivering the expected results. In addition to revenue growth, this is evidenced through accelerating consumption growth trends. For the fourth quarter, consumption for the Company's brands grew 20.6%, up from 14.2% in the third quarter, 3.4% in the second quarter and a negative 6.4% in the first quarter. We have also completed the integration of the acquisitions of Blacksmith Brands and Dramamine and are now focused on developing the long-term potential for these exciting brands. Looking forward, we intend to continue to invest significantly in our core OTC brands to drive long-term sustainable growth and have clear goals to build on the success and momentum heading into fiscal 2012.”

Results by Segment for the Fourth Fiscal Quarter

Revenues for the OTC Healthcare segment in the fourth fiscal quarter were $71.6 million, an increase of 66.5% over the prior year comparable quarter revenues of $43.0 million, primarily due to the addition of the acquired brands in the current year quarter. In addition, our five organic core OTC brands grew 8.4% compared to the prior year comparable quarter, led by increases in Little Remedies®, Chloraseptic®, Clear Eyes®, and Compound W®, slightly offset by a decline in The Doctor's®.

Revenues for the Household Cleaning segment for the fourth fiscal quarter were $24.8 million, an 8.1% decrease over the prior year comparable quarter revenues of $27.0 million. Comet®, Spic and Span® and Chore Boy® continued to face negative category consumption trends and competitive pressures at retail.

Fiscal Year 2011

Revenues for the fiscal year 2011 were $336.5 million, an increase of 15.0% over the prior year's revenues of $292.6 million. Revenues of the acquired Blacksmith Brands and Dramamine® brand, accounted for $38.8 million or 13.3% of the increase while organic revenues for the Company grew $5.1 million or 1.7% during the current year over the prior year.

Income from continuing operations for fiscal 2011 of $29.2 million was 9.0% lower than fiscal 2010 income from continuing operations of $32.1 million. Income from continuing operations for fiscal 2011 was negatively impacted by costs of $10.5 million associated with the above noted acquisitions and $0.2 million of a loss associated with the extinguishment of debt, net of related tax effects. Income from continuing operations for fiscal 2010 was negatively impacted by $1.3 million of a loss on the extinguishment of debt, net of related tax effects. Excluding these impacts, income from continuing operations would have been $39.9 million for the current fiscal year compared to $33.4 million for the prior fiscal year, an increase of 19.3%.

Diluted earnings per share from continuing operations for fiscal 2011 was $0.58, which included the costs associated with the Blacksmith and Dramamine acquisitions and the extinguishment of debt, compared to $0.64 in the prior fiscal year, which included a loss on the extinguishment of debt. Excluding the impact of these charges in each fiscal year, diluted earnings per share from continuing operations in fiscal 2011 would have been $0.79 compared to $0.67 in the prior fiscal year, an increase of 17.9%.

Free Cash Flow and Debt

Free cash flow is a “non-GAAP financial measure” and is presented here because management believes it is a commonly used measure of liquidity, indicative of cash available for debt repayment and acquisitions.

The company defines “free cash flow” as operating cash flow minus capital expenditures.

The Company's free cash flow for the fourth fiscal quarter ended March 31, 2011 was $24.8 million, an increase of 185.5% over the prior year comparable period's free cash flow of $8.7 million. For fiscal year 2011, free cash flow totaled $86.0 million, composed of operating cash flow of $86.7 million minus capital expenditures of $0.7 million. This compares to the prior year free cash flow of $58.7 million, composed of operating cash flow of $59.4 million minus capital expenditures of $0.7 million.

Total indebtedness at March 31, 2011 was $492.0 million, reflecting a recent pay down of $17.5 million. Cash on the balance sheet totaled $13.3 million at March 31, 2011.

Conference Call and Accompanying Slide Presentation

The Company will host a conference call to review its fourth quarter and year end results on May 12, 2011 at 8:30am EDT. The toll-free dial-in numbers are 866-800-8652 within North America and 617-614-2705 outside of North America. The conference pass code is “prestige”. The Company will provide a live internet webcast, a slide presentation to accompany the call, as well as an archived replay, all of which can be accessed from the Investor Relations page of http://prestigebrands.com. The slide presentation can be accessed just before the call from the Investor Relations page of the website by clicking on Webcasts and Presentations.

Telephonic replays will be available for two weeks following the completion of the call and can be accessed at 888-286-8010 within North America and at 617-801-6888 from outside North America. The pass code is 60983170.

About Prestige Brands Holdings, Inc.

The Company markets and distributes brand name over-the-counter and household cleaning products throughout the U.S., Canada, and certain international markets. Core brands include Chloraseptic® sore throat treatments, Clear Eyes® eye care products, Compound W® wart treatments, The Doctor's® NightGuard® dental protector, The Little Remedies® and PediaCare® lines of pediatric over-the-counter products, Efferdent® denture care products, Luden's® throat drops and Dramamine® motion sickness treatment.

Note Regarding Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of the federal securities laws and that are intended to qualify for the Safe Harbor from liability established by the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" generally can be identified by the use of forward-looking terminology such as "assumptions," "target," "guidance," "outlook," "plans," "projection," "may," "will," "would," "expect," "intend," "estimate," "anticipate," "believe, "potential," or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. The "forward-looking statements" include, without limitation, statements regarding our intentions regarding development of the brands that we acquired during fiscal year 2011 and our outlook and plans for the markets in which we compete. These statements are based on management's estimates and assumptions with respect to future events and financial performance and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results could differ materially from those expected as a result of a variety of factors. A discussion of factors that could cause results to vary is included in the Company's Annual Report on Form 10-K and other periodic reports filed with the Securities and Exchange Commission.

Contact: Dean Siegal

914-524-6819

Prestige Brands Holdings, Inc.

Consolidated Statements of Operations

(Unaudited)



	Three Months Ended March 31,					Year Ended March 31,
(In thousands, except share data)	2011		2010			2011			2010
Revenues
Net sales	$	95,629	$	66,374		$	333,715		$	287,552
Other revenues	734		3,567			2,795			5,050
Total revenues	96,363		69,941			336,510			292,602

Cost of Sales
Cost of sales (exclusive of depreciation shown below)	50,058		34,984			165,632			139,158
Gross profit	46,305		34,957			170,878			153,444

Operating Expenses
Advertising and promotion	14,122		6,544			42,897			30,923
General and administrative	11,019		8,108			41,960			34,195
Depreciation and amortization	2,540		2,633			9,876			10,001
Total operating expenses	27,681		17,285			94,733			75,119

Operating income	18,624		17,672			76,145			78,325

Other expense
Interest expense, net	8,809		6,082			27,317			22,935
Loss on extinguishment of debt	—		2,656			300			2,656
Total other expense	8,809		8,738			27,617			25,591

Income from continuing operations before income taxes	9,815		8,934			48,528			52,734
Provision for income taxes	3,401		3,133			19,349			20,664
Income from continuing operations	6,414		5,801			29,179			32,070

Discontinued Operations
Income (loss) from discontinued operations, net of income tax	—		(2,514		)	591			(112		)
Gain (loss) on sale of discontinued operations, net of income tax	—		—			(550		)	157
Net income	$	6,414	$	3,287		$	29,220		$	32,115

Basic earnings per share:
Income from continuing operations	$	0.13	$	0.12		$	0.58		$	0.64
Income (loss) from discontinued operations and gain (loss) from sale of discontinued operations	—		(0.05		)	—			—
Net income	$	0.13	$	0.07		$	0.58		$	0.64

Diluted earnings per share:
Income from continuing operations	$	0.13	$	0.12		$	0.58		$	0.64
Income (loss) from discontinued operations and gain (loss) from sale of discontinued operations	—		(0.05		)	—			—
Net income	$	0.13	$	0.07		$	0.58		$	0.64

Weighted average shares outstanding:
Basic	50,129		50,030			50,081			50,013
Diluted	50,555		50,105			50,338			50,085

Prestige Brands Holdings, Inc.

Consolidated Balance Sheets

(Unaudited)



(In thousands)	March 31,
Assets	2011			2010
Current assets
Cash and cash equivalents	$	13,334		$	41,097
Accounts receivable	44,393			30,621
Inventories	39,751			27,676
Deferred income tax assets	5,292			6,353
Prepaid expenses and other current assets	4,812			4,917
Current assets of discontinued operations	—			1,486
Total current assets	107,582			112,150

Property and equipment	1,444			1,396
Goodwill	154,896			111,489
Intangible assets	786,361			554,359
Other long-term assets	6,635			7,148
Long-term assets of discontinued operations	—			4,870
Total Assets	$	1,056,918		$	791,412

Liabilities and Stockholders' Equity
Current liabilities
Accounts payable	$	21,615		$	12,771
Accrued interest payable	10,313			1,561
Other accrued liabilities	22,280			11,733
Current portion of long-term debt	—			29,587
Total current liabilities	54,208			55,652

Long-term debt
Principal amount	492,000			298,500
Less unamortized discount	(5,055		)	(3,943		)
Long-term debt, net of unamortized discount	486,945			294,557

Deferred income tax liabilities	153,933			112,144

Total Liabilities	695,086			462,353

Stockholders' Equity
Preferred stock - $0.01 par value
Authorized - 5,000 shares
Issued and outstanding - None	—			—
Common stock - $0.01 par value
Authorized - 250,000 shares
Issued - 50,276 shares and 50,154 shares at March 31, 2011 and 2010, respectively	503			502
Additional paid-in capital	387,932			384,027
Treasury stock, at cost - 160 shares and 124 shares at March 31, 2011 and 2010, respectively	(416		)	(63		)
Accumulated deficit	(26,187		)	(55,407		)
Total Stockholders' Equity	361,832			329,059

Total Liabilities and Stockholders' Equity	$	1,056,918		$	791,412

Prestige Brands Holdings, Inc.

Consolidated Statements of Cash Flows

(Unaudited)



	Year Ended March 31,
(In thousands)	2011			2010
Operating Activities
Net income	$	29,220		$	32,115
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,108			11,450
Loss (gain) on sale of discontinued operations	890			(253		)
Deferred income taxes	9,324			11,012
Amortization of deferred financing costs	1,043			1,926
Impairment of goodwill and intangible assets	—			2,751
Stock-based compensation costs	3,575			2,085
Loss on extinguishment of debt	300			2,166
Amortization of debt discount	702			—
Loss on disposal of equipment	153			—
Changes in operating assets and liabilities, net of effects of purchases of businesses
Accounts receivable	4,918			6,404
Inventories	12,443			(3,351		)
Prepaid expenses and other current assets	154			(3,559		)
Accounts payable	1,784			(3,127		)
Accrued liabilities	12,056			(192		)
Net cash provided by operating activities	86,670			59,427

Investing Activities
Purchases of equipment	(655		)	(673		)
Proceeds from sale of property and equipment	12			—
Proceeds from sale of discontinued operations	4,122			7,993
Acquisition of Blacksmith, net of cash acquired	(202,044		)	—
Acquisition of Dramamine	(77,115		)	—
Net cash (used in) provided by investing activities	(275,680		)	7,320

Financing Activities
Proceeds from issuance of debt	—			296,046
Proceeds from issuance of Senior Notes	100,250			—
Proceeds from issuance of Senior Term Loan	112,936			—
Payment of deferred financing costs	(830		)	(6,627		)
Repayment of long-term debt	(51,087		)	(350,250		)
Proceeds from exercise of stock options	331			—
Shares surrendered as payment of tax withholding	(353		)	—
Net cash provided by (used in) financing activities	161,247			(60,831		)
(Decrease) increase in cash	(27,763		)	5,916
Cash - beginning of year	41,097			35,181
Cash - end of year	$	13,334		$	41,097

Interest paid	$	17,509		$	24,820
Income taxes paid	$	11,894		$	15,494

Prestige Brands Holdings, Inc.

Consolidated Statements of Operations

Business Segments

(Unaudited)



	Three Months Ended March 31, 2011
	Over-the- Counter Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	71,390	$	24,239	$	95,629
Other revenues	175		559		734

Total revenues	71,565		24,798		96,363
Cost of sales	33,233		16,825		50,058

Gross profit	38,332		7,973		46,305
Advertising and promotion	12,834		1,288		14,122

Contribution margin	$	25,498	$	6,685	32,183
Other operating expenses					13,559

Operating income					18,624
Other expense					8,809
Provision for income taxes					3,401
Income from continuing operations					6,414
Income from discontinued operations, net of income tax					—
Loss on sale of discontinued operations, net of income tax benefit					—

Net income					$	6,414



	Year Ended March 31, 2011
	Over-the- Counter Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	234,042	$	99,673	$	333,715
Other revenues	543		2,252		2,795

Total revenues	234,585		101,925		336,510
Cost of sales	97,710		67,922		165,632

Gross profit	136,875		34,003		170,878
Advertising and promotion	36,752		6,145		42,897

Contribution margin	$	100,123	$	27,858	127,981
Other operating expenses					51,836

Operating income					76,145
Other expense					27,617
Provision for income taxes					19,349
Income from continuing operations					29,179
Income from discontinued operations, net of income tax					591
Loss on sale of discontinued operations, net of income tax					(550		)

Net income					$	29,220

Prestige Brands Holdings, Inc.

Consolidated Statements of Operations

Business Segments

(Unaudited)



	Three Months Ended March 31, 2010
	Over-the- Counter Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	39,848	$	26,526	$	66,374
Other revenues	3,122		445		3,567

Total revenues	42,970		26,971		69,941
Cost of sales	16,631		18,353		34,984

Gross profit	26,339		8,618		34,957
Advertising and promotion	4,965		1,579		6,544

Contribution margin	$	21,374	$	7,039	28,413
Other operating expenses					10,741

Operating income					17,672
Other expense					8,738
Provision for income taxes					3,133
Income from continuing operations					5,801
Loss from discontinued operations, net of income tax					(2,514		)
Gain on sale of discontinued operations, net of income tax					—

Net income					$	3,287



	Year Ended March 31, 2010
	Over-the- Counter Healthcare		Household Cleaning		Consolidated
(In thousands)
Net sales	$	178,755	$	108,797	$	287,552
Other revenues	3,151		1,899		5,050

Total revenues	181,906		110,696		292,602
Cost of sales	67,040		72,118		139,158

Gross profit	114,866		38,578		153,444
Advertising and promotion	24,264		6,659		30,923

Contribution margin	$	90,602	$	31,919	122,521
Other operating expenses					44,196

Operating income					78,325
Other expense					25,591
Provision for income taxes					20,664
Income from continuing operations					32,070
Loss from discontinued operations, net of income tax					(112		)
Gain on sale of discontinued operations, net of income tax					157

Net income					$	32,115